Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane-associated phosphatidylinositol transfer protein 1 (PITPNM1) is a cytosolic lipid transfer protein that catalyzes the transfer of phosphatidylinositol between membranes and binds phosphatidylinositol, phosphatidic acid, and phosphatidylcholine (affinity: PI > PA > PC)[2][9]. It is essential for maintaining normal levels of diacylglycerol in the Golgi apparatus, proper structure of the endoplasmic reticulum and Golgi, completion of cytokinesis, and protein export from organelles. PITPNM1 has homology to the Drosophila retinal degeneration B protein and plays key regulatory roles in cytoskeleton remodeling and calcium ion binding. Variants in this gene are associated with retinal degeneration and cone-rod dystrophy, and the protein participates in critical glycerophospholipid metabolism and signaling pathways[1][2][3][9].
Lipid transfer inhibitors (theoretical); Modulators of phosphoinositide signaling pathways (theoretical/experimental)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane-associated phosphatidylinositol transfer protein 1 (PITPNM1).